MAP2K7 and Patent ductus arteriosus: To further investigate the dependency of MEK and AKT activity in KRASG12D cell-autonomous signaling, KRASWT and KRASG12D PDA cells were perturbed with MEK (PD-184352) and/or AKT (MK-2206) inhibitors and analyzed by quantitative phosphoproteomics.